Volume Progression in Polycystic Kidney Disease

Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive enlargement of cyst-filled kidneys. A magnetic-resonance–based method was used to determine the rates of change in total kidney volume and cyst volume and iothalamate clearance over a three-year period in patients w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The New England journal of medicine 2006-05, Vol.354 (20), p.2122-2130
Hauptverfasser: Grantham, Jared J, Torres, Vicente E, Chapman, Arlene B, Guay-Woodford, Lisa M, Bae, Kyongtae T, King, Bernard F, Wetzel, Louis H, Baumgarten, Deborah A, Kenney, Phillip J, Harris, Peter C, Klahr, Saulo, Bennett, William M, Hirschman, Gladys N, Meyers, Catherine M, Zhang, Xiaoling, Zhu, Fang, Miller, John P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive enlargement of cyst-filled kidneys. A magnetic-resonance–based method was used to determine the rates of change in total kidney volume and cyst volume and iothalamate clearance over a three-year period in patients with ADPKD without azotemia. Higher rates of kidney enlargement were associated with more rapid decreases in renal function. A magnetic-resonance–based method was used to determine the rates of change in total kidney volume and cyst volume in patients with ADPKD. Higher rates of kidney enlargement were associated with more rapid decreases in renal function. Autosomal dominant polycystic kidney disease (ADPKD) is the most common renal disorder involving a single gene and the fourth leading cause of end-stage renal disease in adults. 1 , 2 Renal cysts contribute to morbidity and can impair the quality of life early in the course of the disease. Pain and gross hematuria are reported in approximately 60 percent of patients. 3 , 4 ADPKD ultimately leads to the destruction of renal parenchyma in more than 50 percent of patients. 5 – 9 Serum creatinine levels rise late in the course of the disease, only after the noncystic parenchyma has incurred serious, irreversible damage. The lack . . .
ISSN:0028-4793
1533-4406
DOI:10.1056/NEJMoa054341